Corporate Profile

Aeterna Zentaris Inc. (TSX: AEZ, NASDAQ: AEZS) is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health.


Contact us:

Canada
Aeterna Zentaris Inc.
1405 du Parc-Technologique Blvd.
Québec, Québec
Canada
G1P 4P5
Phone: (418) 652-8525
Fax: (418) 948-9191
www.aezsinc.com

USA
Aeterna Zentaris, Inc.
315 Sigma Drive, Suite 302D
Summerville, SC 29483
Phone: (843) 900-3223

Germany
Aeterna Zentaris GmbH
Weismüllerstrasse 50
60314 Frankfurt
Germany
Phone: +49 69 42602 3228





Aeterna Zentaris Completes Patient Recruitment for ZoptEC Phase 3 Study with Zoptarelin Doxorubicin in Advanced Endometrial Cancer more...>

Aeterna Zentaris Announces Selection of Ergomed to Conduct Confirmatory Phase 3 Clinical Trial of Macrilen™ in AGHD more...>

Aeterna Zentaris Announces Extension to Regain Compliance with NASDAQ's Minimum Bid Price Rule more...>

Aeterna Zentaris’ Confirmatory Phase 3 Study for Macrilen™ in AGHD Meets EMA’s Study-Design Expectations more...>

Aeterna Zentaris Announces Election of Directors at 2015 Shareholders’ Meeting more...>

Aeterna Zentaris and EMD Serono Finalize Promotional Services Agreement for Saizen® [Somatropin (rDNA origin) for Injection] in the U.S. more...>

Aeterna Zentaris Reports 1st Quarter 2015 Financial and Operating Results more...>
May 8, 2015
First quarter 2015 financial and operating results

More

 
Download PDF (125K)
Download and install Acrobat Reader